CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fountain Biopharma Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fountain Biopharma Inc.
19F-1, No. 3,
Yuanqu Street, San Chong Li,
Phone: +886 226558687p:+886 226558687 Taipei, 115  Taiwan, Republic of China Fax: +886 226558579f:+886 226558579
This company is no longer actively traded on any major stock exchange.
Business Summary
Fountain Biopharma Inc. is a Taiwan-based company principally engaged in the research, development and sales of antibody drugs. The Company's main products include an anti-allergy single-injection antibody, FB825-Anti-CmX; a single-injection antibody, FB704A-Anti-IL6; a biosimilar drug, FB317-Omalizumab, and a biosimilar drug, FB121-Ibalizumab. The Company has not generated any revenue for the past two years.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201912/31/2018Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HuifangHuang 1/1/2016 1/11/2011
Head of Finance QiongyuPan 7/12/2013 7/12/2013
General Manager WeiliLin 11/28/2013 2/10/2011
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 39 (As of 6/30/2014)
Outstanding Shares: 281,773,550 (As of 6/30/2019)
Shareholders: 8,967
Stock Exchange: TPO
Fax Number: +886 226558579


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023